BNR
Burning Rock Biotech Ltd.
NASDAQ · Healthcare · Medical - Diagnostics & Research · CN
$14.71
+8.80%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1.87x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.09x
- Price / sales
- 2.08x
- Price / cash flow
- -85.18x
Enterprise value
- Enterprise value
- $99.4M
- EV / sales
- 1.33x
- EV / EBITDA
- -15.79x
- EV / EBIT
- -10.26x
- Market cap
- $155.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026